Authors


Joshua Seidman, PhD

Latest:

Patient Engagement and Wellness: A Critical Piece of the Puzzle as Health Care Moves to Value-Based Models

Although we have seen some progress through the proliferation of patient-centered medical homes, most clinicians have not fundamentally altered their basic approach to engaging with their patients.



Katherine Lee, PharmD

Latest:

Help Patients Shorten the Duration of a Cold

A few unexpected products, such as honey, could end the misery more quickly than expected.


Joseph Moose, PharmD

Latest:

Pharmacists as Influencers of Patient Adherence

Pharmacists can make the most of their interactions with patients.


Fred M. Eckel RPh, MS, Pharmacy Times Editor-in-Chief

Latest:

Achieving Value

Cost is a part of the value proposition, but it needs to be put in place at the system level.


Rob Osborne, Vice President, Pharma Trade Relations, Accredo

Latest:

Specialty Pharmacy Takes Center Stage in Cancer Care

The oncology pharmaceutical market is rapidly growing and changing.


Max Sherman, BSPharm

Latest:

BCG: The Current Treatment of Choice for Bladder Cancer

Mr. Sherman is president of Sherman Consulting Services Inc.


Lincoln Alexander, PharmD

Latest:

Vaccine Billing Coverage Options: Seasonal Influenza and Future COVID-19 Vaccines

A thorough understanding of immunization billing processes for Medicare, Medicaid, and other third-party payers will be critical to ensure pharmacy staff can efficiently serve their communities and facilitate a smooth reimbursement process.


Erica Wegrzyn, BA, BS, PharmD

Latest:

Treatment of Neuropathic Pain

Chronic pain has been defined by the International Association for the Study of Pain as pain that persists beyond the normal tissue healing time of 3 months, and it may be classified into 3 distinct categories: nociceptive, neuropathic, and a mixture of the two.


Kavita V. Nair, PhD

Latest:

Impact of Medicare Part D on Utilization and Expenditures

Examination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.


Dan Leonard, MA

Latest:

Opportunities and Challenges With Value-Based Contracting

Given the need to provide patients with access to effective medications, it is likely that we will see more value-based contracts in the future; however, some key operational, communications, and regulatory barriers will need to be addressed first.


Jennifer Gershman, PharmD

Latest:

Oncology Overview: Taking a Closer Look at Axicabtagene Ciloleucel

Axicabtagene ciloleucel (Yescarta) received accelerated FDA approval on March 5, 2021, for the treatment of adult patients with relapsed or refractory FL after 2 or more lines of systemic therapy.


Douglas Jennings, PharmD, FCCP, FAHA

Latest:

All That Is Old Becomes New Again: New Roles for Old, Antiplatelets in STEMI

This article discusses the potential role of tirofiban as a complementary agent to the newer oral P2Y12 receptor blockers in STEMI patients.



Tina J Kanmaz, PharmD

Latest:

The Impact of COVID-19 on Recent Pharmacy School Graduates

Pharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.


Deepika Sivakumar, PharmD

Latest:

Vaccinations in the Emergency Department: Current and Emerging Practices to Boost Public Health

Piloting new emergency department-based vaccination campaigns and fine-tuning existing programs may reduce morbidity and mortality associated with vaccine-preventable diseases.


Brian Isetts, PhD, BCPS, FAPhA

Latest:

Be Careful What You Wish For

Expectations will be high for pharmacists responsible for comprehensive medication therapy and patient outcomes.


Bernice Lee

Latest:

Manage Acute Pain in Those Using Opioids

Pharmacists play a vital role in managing regimens and ensuring proper compliance.


Dean Erhardt, MBA, President

Latest:

Federal Drug Price Plan Rollout and Other Trends to Watch

The FDA recently launched one of its first programs following the release of the Trump administration’s new drug price plan.



Mohammad J. Tafreshi, PharmD, BCPS

Latest:

Management of VTE: 10 New Recommendations

Dr. Tafreshi is professor and director of cardiology pharmacy practice residency at Midwestern University College of Pharmacy-Glendale (MWU-CPG), Glendale, Ariz. At the time of submission of this article, Dr. Patterson was a senior pharmacy student at MWU-CPG.


Neelu P. Patil, PharmD, BCPS

Latest:

Pharmacy Accreditation 101

Best strategies to help the pharmacy department get ready for a survey and stay ready.



Gary M. Owens, MD

Latest:

A Medical Director Perspective on Specialty Pharmacy

This article reviews current drug therapies for heart failure and therapy integration into a patient care framework improving patient adherence and quality of life and decreasing risk of readmission to acute care facilities.


Vishal Bali, MS, PhD

Latest:

Does Medication Persistence in Diabetes Affect the Risk Of Hospitalization In The Short-Term?

An evaluation of the impact of persistence to oral antidiabetic medication on reducing the risk of hospitalization in adult patients with type 2 diabetes.


Elizabeth R. Pfoh, MPH

Latest:

The Comparative Value of 3 Electronic Sources of Medication Data

Combining medication history information from multiple sources improves the completeness and accuracy of the medication information.




Stephanie A. Gernant, PharmD, MS

Latest:

Pharmacists in ACOs, Part 1: Accountable Care Basics Every Pharmacist Should Know

While trying to explain his work on quantum mechanics, physicist Richard Feynman famously quipped, If anybody says they understand it, they don't understand it." The same could be said about the speed-of-light changes occurring within our nation's health care system.